CeriBell (CBLL) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
2 Jun, 2026Opening remarks and agenda
Meeting called to order virtually at 9:00 A.M. Pacific Time, with agenda and rules available online.
Directors and executive officers introduced, including the Chair, CEO, CFO, CTO, and General Counsel.
Representatives from the independent auditor and Inspector of Elections present.
Board and executive committee updates
Two current directors, Josef Parvizi and Rebecca Robertson, nominated for re-election by the Nominating and Corporate Governance Committee.
Board recommends voting in favor of both nominees.
Shareholder proposals
Proposal One: Election of two directors to serve until the 2029 annual meeting.
Proposal Two: Ratification of PricewaterhouseCoopers LLP as independent registered public accounting firm for fiscal year 2026.
Partial view of Summaries dataset, powered by Quartr API
Latest events from CeriBell
- AI-driven EEG platform accelerates acute seizure diagnosis, fueling rapid growth and market expansion.CBLL
Corporate presentation1 Jul 2026 - Rapid EEG platform with AI expands into new markets, driving strong growth and clinical adoption.CBLL
46th Annual William Blair Growth Stock Conference3 Jun 2026 - Record Q1 growth, new hospital strategies, and strong margins highlight ongoing expansion.CBLL
Bank of America Global Healthcare Conference 202620 May 2026 - Q1 revenue up 29% to $26.5M, net loss widens, and full-year guidance is raised.CBLL
Q1 202611 May 2026 - Strong 2026 growth outlook driven by new indications, sales expansion, and high-margin operations.CBLL
TD Cowen 46th Annual Health Care Conference29 Apr 2026 - Virtual vote set for June 2, 2026, on director elections and auditor ratification.CBLL
Proxy filing20 Apr 2026 - Annual meeting to elect directors, ratify auditor, and review governance, compensation, and ESG.CBLL
Proxy filing20 Apr 2026 - AI-powered EEG platform accelerates acute care diagnosis, fueling rapid growth and market expansion.CBLL
Corporate presentation5 Mar 2026 - Rapid EEG platform drives strong growth and expands into new neurological indications.CBLL
47th Annual Raymond James Institutional Investor Conference2 Mar 2026